SLC47A1 and chronic myelogenous leukemia, BCR-ABL1 positive: For instance, high expression of SLC47A1 has been linked to reduced effectiveness of metformin in metastatic colorectal cancer and limited imatinib uptake in non-responding chronic myeloid leukemia patients.